Follow The Filings

PVLA Palvella Therapeutics

Palvella Therapeutics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by PVLA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PVLA insider trades
  • $850K bought by 2 insiders
  • $49K sold by 1 insider outside a trading plan
  • $13.8M sold by 2 insiders under 10b5-1 plans
  1. Kathleen Goin COO
    Planned sale
    $537K 4,313 shares at $124.58 100% of stake
    Traded Oct 21 Filed Oct 23
    ↗
  2. George M Jenkins Director
    Planned sale
    $3.6M 27,500 shares at $130.16 17% of stake
    Traded Oct 12–14 Filed Oct 14
    ↗
  3. Kathleen Goin COO
    Planned sale
    $655K 4,302 shares at $152.24 100% of stake
    Traded Sep 16 Filed Sep 18
    ↗
  4. George M Jenkins Director
    Planned sale
    $4.2M 27,500 shares at $151.53 15% of stake
    Traded Sep 11–15 Filed Sep 15
    ↗
  5. Christopher P Kiritsy Director
    Sale
    $49K 313 shares at $157.00 56% of stake
    Traded Sep 2 Filed Sep 4
    ↗
  6. Kathleen Goin COO
    Planned sale
    $655K 4,302 shares at $152.21 100% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  7. Kathleen Goin COO
    Planned sale
    $642K 4,302 shares at $149.28 100% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  8. Kathleen Goin COO
    Planned sale
    $476K 4,302 shares at $110.73 100% of stake
    Traded Jun 17 Filed Jun 22
    ↗
  9. Kathleen Goin COO
    Planned sale
    $476K 4,302 shares at $110.56 100% of stake
    Traded May 20 Filed May 22
    ↗
  10. Kathleen Goin COO
    Planned sale
    $547K 4,302 shares at $127.24 100% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  11. George M Jenkins Director
    Buy
    $50K 445 shares at $112.30 +0.2% to stake
    Traded Mar 30 Filed Apr 1
    ↗
  12. Kathleen Goin COO
    Planned sale
    $508K 4,302 shares at $117.99 100% of stake
    Traded Mar 18 Filed Mar 20
    ↗
  13. George M Jenkins Director
    Buy
    $500K 4,000 shares at $125.00 +2.2% to stake
    Traded Feb 27 Filed Mar 2
    ↗
  14. Elaine J Heron Director
    Buy
    $300K 2,400 shares at $125.00 +5.3% to stake
    Traded Feb 27 Filed Mar 2
    ↗
  15. Kathleen Goin COO
    Planned sale
    $342K 4,302 shares at $79.40 100% of stake
    Traded Feb 18 Filed Feb 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 26 option exercises.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 8.01,9.01 Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated about 12 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.